combination glp-1 and sglt2 Effect of treatment with glucagon-like peptide-1 receptor agonists sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study GLP-1-RA and DPP-4 inhibitors in

Even intravenous administration of GLP-1 at a physiological postprandial dose of 0.3 pmol/kg/min significantly slowed the rate of gastric emptying in healthy subjects, bringing them into a state of gastroparesis (Little et al., 2006)

Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE

NAC is well absorbed, and unlike L cysteine, is virtually non-toxic

Tirzepatide (Mounjaro) Tirzepatide is a dual GIP + GLP-1 receptor agonist

Federal legislation like the Treat and Reduce Obesity Act, if passed, would remove the federal exclusion that allows states to deny coverage for anti-obesity medications

Suggested Use: Take 12 capsules daily